These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 38822427)

  • 1. Knockout mice with pituitary malformations help identify human cases of hypopituitarism.
    Martinez-Mayer J; Brinkmeier ML; O'Connell SP; Ukagwu A; Marti MA; Miras M; Forclaz MV; Benzrihen MG; Cheung LYM; Camper SA; Ellsworth BS; Raetzman LT; Pérez-Millán MI; Davis SW
    Genome Med; 2024 May; 16(1):75. PubMed ID: 38822427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sonic Hedgehog mutations are not a common cause of congenital hypopituitarism in the absence of complex midline cerebral defects.
    Paulo SS; Fernandes-Rosa FL; Turatti W; Coeli-Lacchini FB; Martinelli CE; Nakiri GS; Moreira AC; Santos AC; de Castro M; Antonini SR
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):562-9. PubMed ID: 25056824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variations in PROKR2, but not PROK2, are associated with hypopituitarism and septo-optic dysplasia.
    McCabe MJ; Gaston-Massuet C; Gregory LC; Alatzoglou KS; Tziaferi V; Sbai O; Rondard P; Masumoto KH; Nagano M; Shigeyoshi Y; Pfeifer M; Hulse T; Buchanan CR; Pitteloud N; Martinez-Barbera JP; Dattani MT
    J Clin Endocrinol Metab; 2013 Mar; 98(3):E547-57. PubMed ID: 23386640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HESX1 mutations are an uncommon cause of septooptic dysplasia and hypopituitarism.
    McNay DE; Turton JP; Kelberman D; Woods KS; Brauner R; Papadimitriou A; Keller E; Keller A; Haufs N; Krude H; Shalet SM; Dattani MT
    J Clin Endocrinol Metab; 2007 Feb; 92(2):691-7. PubMed ID: 17148560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary Transcription Factor Mutations Leading to Hypopituitarism.
    Gergics P
    Exp Suppl; 2019; 111():263-298. PubMed ID: 31588536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activating mutations in BRAF disrupt the hypothalamo-pituitary axis leading to hypopituitarism in mice and humans.
    Gualtieri A; Kyprianou N; Gregory LC; Vignola ML; Nicholson JG; Tan R; Inoue SI; Scagliotti V; Casado P; Blackburn J; Abollo-Jimenez F; Marinelli E; Besser REJ; Högler W; Karen Temple I; Davies JH; Gagunashvili A; Robinson ICAF; Camper SA; Davis SW; Cutillas PR; Gevers EF; Aoki Y; Dattani MT; Gaston-Massuet C
    Nat Commun; 2021 Apr; 12(1):2028. PubMed ID: 33795686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural pituitary abnormalities associated with CHARGE syndrome.
    Gregory LC; Gevers EF; Baker J; Kasia T; Chong K; Josifova DJ; Caimari M; Bilan F; McCabe MJ; Dattani MT
    J Clin Endocrinol Metab; 2013 Apr; 98(4):E737-43. PubMed ID: 23526466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterozygous mutation of HESX1 causing hypopituitarism and multiple anatomical malformations without features of septo-optic dysplasia.
    Corneli G; Vivenza D; Prodam F; Di Dio G; Vottero A; Rapa A; Bellone S; Bernasconi S; Bona G
    J Endocrinol Invest; 2008 Aug; 31(8):689-93. PubMed ID: 18852528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the sonic hedgehog signalling pathway in patients with midline defects and congenital hypopituitarism.
    Gregory LC; Gaston-Massuet C; Andoniadou CL; Carreno G; Webb EA; Kelberman D; McCabe MJ; Panagiotakopoulos L; Saldanha JW; Spoudeas HA; Torpiano J; Rossi M; Raine J; Canham N; Martinez-Barbera JP; Dattani MT
    Clin Endocrinol (Oxf); 2015 May; 82(5):728-38. PubMed ID: 25327282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital hypopituitarism in two brothers with a duplication of the 'acrogigantism gene' GPR101: clinical findings and review of the literature.
    Elizabeth MSM; Verkerk AJMH; Hokken-Koelega ACS; Verlouw JAM; Argente J; Pfaeffle R; Neggers SJCMM; Visser JA; de Graaff LCG
    Pituitary; 2021 Apr; 24(2):229-241. PubMed ID: 33184694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The phenotypic spectrum associated with OTX2 mutations in humans.
    Gregory LC; Gergics P; Nakaguma M; Bando H; Patti G; McCabe MJ; Fang Q; Ma Q; Ozel AB; Li JZ; Poina MM; Jorge AAL; Benedetti AFF; Lerario AM; Arnhold IJP; Mendonca BB; Maghnie M; Camper SA; Carvalho LRS; Dattani MT
    Eur J Endocrinol; 2021 May; 185(1):121-135. PubMed ID: 33950863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic aspects of hypothalamic and pituitary gland development.
    McCabe MJ; Dattani MT
    Handb Clin Neurol; 2014; 124():3-15. PubMed ID: 25248576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel homozygous HESX1 mutation causes panhypopituitarism without midline defects and optic nerve anomalies.
    Durmaz B; Cogulu O; Dizdarer C; Stobbe H; Pfaeffle R; Ozkinay F
    J Pediatr Endocrinol Metab; 2011; 24(9-10):779-82. PubMed ID: 22145475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of mouse models carrying the I26T and R160C substitutions in the transcriptional repressor HESX1 as models for septo-optic dysplasia and hypopituitarism.
    Sajedi E; Gaston-Massuet C; Signore M; Andoniadou CL; Kelberman D; Castro S; Etchevers HC; Gerrelli D; Dattani MT; Martinez-Barbera JP
    Dis Model Mech; 2008; 1(4-5):241-54. PubMed ID: 19093031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary gland development: an update.
    Bancalari RE; Gregory LC; McCabe MJ; Dattani MT
    Endocr Dev; 2012; 23():1-15. PubMed ID: 23182816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Genetic Diagnoses in Septo-Optic Dysplasia.
    Reis LM; Seese S; Maheshwari M; Basel D; Weik L; McCarrier J; University Of Washington Center For Mendelian Genomics ; Semina EV
    Genes (Basel); 2022 Jun; 13(7):. PubMed ID: 35885948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation analysis of POUF-1, PROP-1 and HESX-1 show low frequency of mutations in children with sporadic forms of combined pituitary hormone deficiency and septo-optic dysplasia.
    Rainbow LA; Rees SA; Shaikh MG; Shaw NJ; Cole T; Barrett TG; Kirk JM
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):163-8. PubMed ID: 15670191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide screening reveals the genetic basis of mammalian embryonic eye development.
    Chee JM; Lanoue L; Clary D; Higgins K; Bower L; Flenniken A; Guo R; Adams DJ; Bosch F; Braun RE; Brown SDM; Chin HG; Dickinson ME; Hsu CW; Dobbie M; Gao X; Galande S; Grobler A; Heaney JD; Herault Y; de Angelis MH; Mammano F; Nutter LMJ; Parkinson H; Qin C; Shiroishi T; Sedlacek R; Seong JK; Xu Y; ; Brooks B; McKerlie C; Lloyd KCK; Westerberg H; Moshiri A
    BMC Biol; 2023 Feb; 21(1):22. PubMed ID: 36737727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel FGF8 mutations associated with recessive holoprosencephaly, craniofacial defects, and hypothalamo-pituitary dysfunction.
    McCabe MJ; Gaston-Massuet C; Tziaferi V; Gregory LC; Alatzoglou KS; Signore M; Puelles E; Gerrelli D; Farooqi IS; Raza J; Walker J; Kavanaugh SI; Tsai PS; Pitteloud N; Martinez-Barbera JP; Dattani MT
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1709-18. PubMed ID: 21832120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Truncating RAX Mutations: Anophthalmia, Hypopituitarism, Diabetes Insipidus, and Cleft Palate in Mice and Men.
    Brachet C; Kozhemyakina EA; Boros E; Heinrichs C; Balikova I; Soblet J; Smits G; Vilain C; Mathers PH
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2925-2930. PubMed ID: 30811539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.